- Home
- ZKH vs EBS Comparison
ZKH vs EBS Comparison
Compare ZKH & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- EBS
- Stock Information
- Founded
- ZKH 1998
- EBS 1998
- Country
- ZKH China
- EBS United States
- Employees
- ZKH N/A
- EBS N/A
- Industry
- ZKH
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- ZKH
- EBS Health Care
- Exchange
- ZKH Nasdaq
- EBS Nasdaq
- Market Cap
- ZKH 472.2M
- EBS 393.9M
- IPO Year
- ZKH 2023
- EBS 2006
- Fundamental
- Price
- ZKH $3.12
- EBS $6.29
- Analyst Decision
- ZKH Buy
- EBS Strong Buy
- Analyst Count
- ZKH 1
- EBS 3
- Target Price
- ZKH $4.00
- EBS $14.33
- AVG Volume (30 Days)
- ZKH 27.4K
- EBS 985.0K
- Earning Date
- ZKH 05-20-2025
- EBS 08-05-2025
- Dividend Yield
- ZKH N/A
- EBS N/A
- EPS Growth
- ZKH N/A
- EBS N/A
- EPS
- ZKH N/A
- EBS N/A
- Revenue
- ZKH $1,217,705,644.00
- EBS $965,400,000.00
- Revenue This Year
- ZKH $11.72
- EBS N/A
- Revenue Next Year
- ZKH $10.57
- EBS $18.88
- P/E Ratio
- ZKH N/A
- EBS N/A
- Revenue Growth
- ZKH 2.24
- EBS N/A
- 52 Week Low
- ZKH $2.50
- EBS $4.02
- 52 Week High
- ZKH $4.31
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- ZKH 55.28
- EBS 52.68
- Support Level
- ZKH $2.87
- EBS $6.04
- Resistance Level
- ZKH $3.22
- EBS $6.47
- Average True Range (ATR)
- ZKH 0.24
- EBS 0.32
- MACD
- ZKH 0.01
- EBS -0.06
- Stochastic Oscillator
- ZKH 83.05
- EBS 38.89
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.